Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A Randomised Controlled Trial

BACKGROUND: This was the first study to investigate the reactogenicity and immunogenicity of heterologous or fractional second dose COVID-19 vaccine regimens in adolescents. METHODS: A phase II, single-blind, multi-centre, randomised-controlled trial recruited across seven UK sites from September to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Eimear, Greenland, Melanie, de Whalley, Philip C S, Aley, Parvinder K, Plested, Emma L, Singh, Nisha, Koleva, Stanislava, Tonner, Sharon, Macaulay, Grace C, Read, Robert C, Ramsay, Mary, Cameron, J Claire, Turner, David P J, Heath, Paul T, Bernatoniene, Jolanta, Connor, Philip, Cathie, Katrina, Faust, Saul N, Banerjee, Indraneel, Cantrell, Liberty, Mujadidi, Yama F, Belhadef, Hanane Trari, Clutterbuck, Elizabeth A, Anslow, Rachel, Valliji, Zara, James, Tim, Hallis, Bassam, Otter, Ashley David, Lambe, Teresa, Nguyen-Van-Tam, Jonathan S, Minassian, Angela M, Liu, Xinxue, Snape, Matthew D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275659/
https://www.ncbi.nlm.nih.gov/pubmed/37331429
http://dx.doi.org/10.1016/j.jinf.2023.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275659/
https://www.ncbi.nlm.nih.gov/pubmed/37331429
http://dx.doi.org/10.1016/j.jinf.2023.06.007

Ejemplares similares